GENFIT (EPA:GNFT) | Finanzwire

Basculer en Français

9982	Companies
202335	Keywords
132958	Articles
107443	Press releases

Home
Companies
GENFIT

BRIEF

published on 02/12/2026 at 18:40, 20 days 21 hours ago

GENFIT welcomes a $20M milestone payment thanks to Iqirvo® performance

Biopharmaceutical GENFIT Ipsen Iqirvo® Stage Payment
BRIEF

published on 02/12/2026 at 18:40, 20 days 21 hours ago

GENFIT Secures US$20M Milestone with Iqirvo® Success

Clinical Trials Biopharmaceutical GENFIT Milestone Payment Iqirvo
PRESS RELEASE

published on 02/12/2026 at 18:35, 20 days 21 hours ago

GENFIT to receive US$20M milestone after Ipsen’s Iqirvo® exceeds the US$200M threshold in its first full year of net sales
GENFIT receives US$20M milestone from Ipsen as Iqirvo® surpasses US$200M net sales threshold in 2025. Phase 3 in PSC confirmed. CCA Phase 1b study progressing as planned. Financial position reinforced

Net Sales Phase 3 GENFIT Milestone Payment Ipsen
BRIEF

published on 11/10/2025 at 07:50, 3 months 25 days ago

GENFIT Collaborates with EVerZom on Exosome-Based Therapy for Liver Failure

GENFIT ACLF EVerZom Exosome Therapy EViv
PRESS RELEASE

published on 11/10/2025 at 07:45, 3 months 25 days ago

GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF
GENFIT collaborates with EVerZom to advance exosome-based regenerative technology in ACLF, aiming for clinical development. The partnership combines expertise in exosome and liver disease research

Exosome GENFIT ACLF EVerZom Regenerative Technology
BRIEF

published on 11/10/2025 at 07:35, 3 months 25 days ago

GENFIT Reveals Encouraging Preclinical Findings on NTZ/G1090N for ACLF Treatment

Preclinical Data GENFIT ACLF Liver Meeting 2025 G1090N
PRESS RELEASE

published on 11/10/2025 at 07:30, 3 months 25 days ago

GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting® 2025
GENFIT presents promising new preclinical data on NTZ/G1090N for the treatment of ACLF at The Liver Meeting® 2025. G1090N optimizes dosing flexibility for varying patient conditions

Preclinical Data GENFIT NTZ/G1090N ACLF Treatment The Liver Meeting 2025
BRIEF

published on 10/30/2025 at 21:05, 4 months 5 days ago

GENFIT to Delist ADSs from Nasdaq Global Select Market

Euronext Paris Operational Efficiency Nasdaq Delisting GENFIT ADS Deregistration
PRESS RELEASE

published on 10/30/2025 at 21:00, 4 months 5 days ago

GENFIT announces intention to voluntarily delist American Depositary Shares from The Nasdaq Global Select Market
GENFIT announces intention to voluntarily delist American Depositary Shares from The Nasdaq Global Select Market. Decision reflects strategic intent for operational efficiency

Operational Efficiency Nasdaq Delist GENFIT Strategic Intent
BRIEF

published on 10/28/2025 at 22:15, 4 months 7 days ago

GENFIT Unveils ACLF Pipeline Developments at AASLD Meeting 2025

Liver Diseases GENFIT Ipsen ACLF Liver Meeting 2025

1 2 ... 7

Accesswire

Published on 03/05/2026 at 14:00, 1 hour 45 minutes ago

EQ Inc. Secures Strategic Partnership with Global Card Network to Expand Integrated Rewards Across Canada
Published on 03/05/2026 at 14:00, 1 hour 45 minutes ago

GameSquare's Stream Hatchet Publishes 2025 YouTube Gaming Trends Report
Published on 03/05/2026 at 14:00, 1 hour 45 minutes ago

Horizon Aircraft's Unique VTOL Delivers Up to 75% Lower Operating Costs Than Helicopters
Published on 03/05/2026 at 13:40, 2 hours 5 minutes ago

Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences
Published on 03/05/2026 at 13:30, 2 hours 15 minutes ago

Vox Royalty Provides 2026 Guidance and Increases Quarterly Dividend

View all ACCESSWIRE

EQS Group

Published on 03/05/2026 at 15:32, 13 minutes ago

Correction of a release from 31.12.2025 07:30 GMT/BST - Restoration- daVictus Plc
Published on 03/05/2026 at 15:07, 37 minutes ago

Form 8.3 - The Vanguard Group, Inc.: NCC Group plc
Published on 03/05/2026 at 15:07, 38 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 03/05/2026 at 15:06, 39 minutes ago

Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 03/05/2026 at 15:05, 40 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc

Les Echos

Published on 03/05/2026 at 13:20, 2 hours 24 minutes ago

Voting rights
Published on 03/05/2026 at 07:30, 8 hours 15 minutes ago

Share buyback finalized
Published on 03/04/2026 at 23:50, 15 hours 55 minutes ago

Total number of voting rights and shares making up the share capital at February 28, 2026
Published on 03/04/2026 at 18:00, 21 hours 45 minutes ago

Disclosure of Share Capital and Voting Rights as of February 28, 2026
Published on 03/04/2026 at 17:45, 22 hours ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE